DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Dekaris I, Gabric N, Draca N. et al.
Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab.
Graefes Arch Clin Exp Ophthalmol 2015;
253: 287-294
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.